| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A case series of three male patients with blastic plasmocytoid dendritic cell neoplasm
|
Osmancevic, A
|
|
|
173 |
S1 |
p. S33-S34
|
artikel
|
| 2 |
Adult T-cell leukemia-lymphoma (ATLL) with initial cutaneous manifestation and lymphatic drainage
|
Tonellotto, L
|
|
|
173 |
S1 |
p. S43-S44
|
artikel
|
| 3 |
A 9-gene prognostic signature for predicting survival outcome in mycosis fungoides
|
Alberti-Violetti, S
|
|
|
173 |
S1 |
p. S8
|
artikel
|
| 4 |
Aggressive cytotoxic dermal lymphomas of the earlobe: a single-institution case series
|
Guitart, J
|
|
|
173 |
S1 |
p. S12
|
artikel
|
| 5 |
Allogenic hematopoietic stem-cell transplantation (allo-HSCT) after mogamulizumab treatment in mycosis fungoides (MF) or Sézary syndrome (SS)
|
Lechowicz, MJ
|
|
|
173 |
S1 |
p. S41-S42
|
artikel
|
| 6 |
A post-hoc analysis of clinical trial data shows that prior phototherapy does not affect response to chlormethine gel in patients with mycosis fungoides
|
Assaf, C
|
|
|
173 |
S1 |
p. S26-S27
|
artikel
|
| 7 |
Artificial intelligence-assisted probability scoring for differentiation of early mycosis fungoides and benign inflammatory dermatoses on H&E stained pathology slides of skin biopsies
|
Doeleman, T
|
|
|
173 |
S1 |
p. S11
|
artikel
|
| 8 |
AUTHOR INDEX
|
|
|
|
173 |
S1 |
p. S53-S58
|
artikel
|
| 9 |
Baseline radiographic imaging is useful in identifying risk factors for survival and lymph node progression
|
Allen, PB
|
|
|
173 |
S1 |
p. S13-S14
|
artikel
|
| 10 |
Bipolar mucosal primary cutaneous peripheral T cell lymphoma ‘not otherwise specified’
|
Grotta, G
|
|
|
173 |
S1 |
p. S35-S36
|
artikel
|
| 11 |
Boost of innate immunity cytokines as biomarkers of response to extracorporeal photopheresis in leukemic cutaneous T-cell lymphoma patients
|
Tsai, YC
|
|
|
173 |
S1 |
p. S5
|
artikel
|
| 12 |
Brentuximab vedotin in the treatment of cutaneous T-cell lymphomas: data from the Spanish Primary Cutaneous Lymphoma Registry
|
Muniesa, C
|
|
|
173 |
S1 |
p. S40-S41
|
artikel
|
| 13 |
Broad-band ultraviolet A combined with narrow-band ultraviolet B: an effective modality for early folliculotropic mycosis fungoides and early mycosis fungoides refractory to narrow-band ultraviolet B
|
Amitay-Laish, I
|
|
|
173 |
S1 |
p. S24
|
artikel
|
| 14 |
CCR8 is a new therapeutic target in cutaneous T-cell lymphomas
|
de Masson, A
|
|
|
173 |
S1 |
p. S7
|
artikel
|
| 15 |
CD8+ T lymphocytes in hypopigmented mycosis fungoides: malignant cells or reactive clone?
|
Cao, S
|
|
|
173 |
S1 |
p. S14-S15
|
artikel
|
| 16 |
Characterization of CD39 expression in cutaneous T cell lymphomas
|
Battesti, GB
|
|
|
173 |
S1 |
p. S28
|
artikel
|
| 17 |
Chemotherapy provides less durable disease control in comparison to other systemic therapies in advanced-stage mycosis fungoides and Sezary syndrome
|
Rooke, DR
|
|
|
173 |
S1 |
p. S45
|
artikel
|
| 18 |
Chimerized anti-ICOS 314.8 monoclonal antibodies inhibit tumor cells and regulatory T cells in patients with Sézary syndrome
|
Amatore, FA
|
|
|
173 |
S1 |
p. S15-S16
|
artikel
|
| 19 |
Clinical characteristics, treatment patterns, and outcomes of cytotoxic cutaneous T-cell lymphomas
|
Mou, D
|
|
|
173 |
S1 |
p. S21-S22
|
artikel
|
| 20 |
Clinical outcomes of single-agent chemotherapy in a diverse cohort of patients with recalcitrant cutaneous T-cell lymphoma
|
Weiner, D
|
|
|
173 |
S1 |
p. S23
|
artikel
|
| 21 |
Combination of JAKi and MAPKi exerts antiangionenic potential in cutaneous T-cell lymphoma
|
Karagianni, F
|
|
|
173 |
S1 |
p. S5
|
artikel
|
| 22 |
Combination of liposomal doxorrubicin, brentuximab vedotin and extracorporeal photopheresis in refractory transformed CD30+ folliculotropic mycosis fungoides followed by allogeneic stem cell transplantation
|
Cardona, LP Gonzalez
|
|
|
173 |
S1 |
p. S39-S40
|
artikel
|
| 23 |
Combination therapy of brentuximab vedotin and low dose gemcitabine in an advanced CTCL
|
Vinh, K
|
|
|
173 |
S1 |
p. S46
|
artikel
|
| 24 |
Combination therapy with chlormethine gel and narrow-band ultraviolet B for patients with mycosis fungoides: a case series
|
Gleason, L
|
|
|
173 |
S1 |
p. S23-S24
|
artikel
|
| 25 |
Comparative analysis of the clinical, histopathological and molecular genetic features of 29 cases comprising cutaneous B-cell lymphomas and B-cell pseudolymphomas in Singapore
|
Tee, SI
|
|
|
173 |
S1 |
p. S38
|
artikel
|
| 26 |
Copyright Page
|
|
|
|
173 |
S1 |
p. vi
|
artikel
|
| 27 |
Cutaneous lymphocyte antigen (CLA) is a potential therapeutic target in cutaneous T cell lymphoma
|
Poglio, S
|
|
|
173 |
S1 |
p. S5-S6
|
artikel
|
| 28 |
Cutaneous T-cell lymphomas treated with pegylated interferon a-2a (Peg-INF): a real-world experience from an Italian expert referral single centre
|
Torre, E
|
|
|
173 |
S1 |
p. S49-S50
|
artikel
|
| 29 |
Diagnostic and therapeutic impact of microRNAs in cutaneous T-cell lymphoma
|
Papadaki, M
|
|
|
173 |
S1 |
p. S30
|
artikel
|
| 30 |
Different subtypes of lymphomatoid papulosis are more overlapping than expected: an analysis of published histologic patterns and criteria
|
Fricke, T
|
|
|
173 |
S1 |
p. S11-S12
|
artikel
|
| 31 |
Digital quantitative detection of DNA methylation biomarkers: a helpful tool in the early diagnosis of Sézary syndrome
|
Zoutman, WH
|
|
|
173 |
S1 |
p. S7-S8
|
artikel
|
| 32 |
Dimethyl fumarate (DMF) therapy in CTCL: final results from a clinical phase II study
|
Nicolay, JP
|
|
|
173 |
S1 |
p. S22-S23
|
artikel
|
| 33 |
Distinction between CTCL and inflammatory dermatoses using mRNA expression of cancer-associated fibroblast markers from skin biopsies
|
Dobos, G
|
|
|
173 |
S1 |
p. S28
|
artikel
|
| 34 |
Dual blocking of CD47 and PD-L1 increases innate and adaptive immune responses in CTCL
|
Han, Z
|
|
|
173 |
S1 |
p. S2-S3
|
artikel
|
| 35 |
Durable complete remission in Sézary syndrome using extracorporal photopheresis: the role of maintenance treatment on a case series
|
Zidane, M
|
|
|
173 |
S1 |
p. S50
|
artikel
|
| 36 |
Early detection of relapse in Sézary syndrome: the added value of KIR3DL2, T-plastin, Twist and Tox for clinical routine
|
Dobos, G
|
|
|
173 |
S1 |
p. S30
|
artikel
|
| 37 |
Early versus advanced stage folliculotropic mycosis fungoides survival analysis in a reference Latin American center
|
Cely, HC Pérez
|
|
|
173 |
S1 |
p. S9-S10
|
artikel
|
| 38 |
Editorial Board
|
|
|
|
173 |
S1 |
p. ii
|
artikel
|
| 39 |
Efficiency of textile photodynamic therapy for mycosis fungoides
|
Toulemonde, E
|
|
|
173 |
S1 |
p. S46-S47
|
artikel
|
| 40 |
Elevated A-to-I RNA editing in leukemic cutaneous T-cell lymphoma
|
Moyal, L
|
|
|
173 |
S1 |
p. S31
|
artikel
|
| 41 |
Estimates of the rate of growth of lymph nodes measured volumetrically predicts survival in cutaneous T-cell lymphoma (CTCL)
|
Fahmy, LM
|
|
|
173 |
S1 |
p. S36
|
artikel
|
| 42 |
Evaluation of the role of different cell populations and immune regulators in mycosis fungoides microenvironment
|
Pavlidis, A
|
|
|
173 |
S1 |
p. S17
|
artikel
|
| 43 |
Exacerbation of mycosis fungoides masquerading as psoriasis under cytokine-pathway blockers
|
Blanchard, G
|
|
|
173 |
S1 |
p. S48-S49
|
artikel
|
| 44 |
Final report of PIMTO-MF clinical trial: multicenter, phase II trial for treatment of early MF with topical pimecrolimus
|
Ortiz-Romero, PL
|
|
|
173 |
S1 |
p. S44-S45
|
artikel
|
| 45 |
First xenograft and cell line of primary cutaneous diffuse large B-cell lymphoma, leg type
|
Prochazkova-Carlotti, M
|
|
|
173 |
S1 |
p. S16
|
artikel
|
| 46 |
Health-related quality of life effect of mogamulizumab by patient blood involvement
|
Zinzani, PL
|
|
|
173 |
S1 |
p. S43
|
artikel
|
| 47 |
Histiocytoid Sweet’s Syndrome in a patient with myelodysplastic syndrome with multilineage dysplasia (MDS-MLD), and monoclonal gammopathy of undetermined significance (MGUS) IgG kappa type
|
Pavlova, O
|
|
|
173 |
S1 |
p. S12-S13
|
artikel
|
| 48 |
ICOSL: a new diagnostic marker and a new therapeutic target using an ICOS-Fc construct in Sézary syndrome?
|
Ortonne, N
|
|
|
173 |
S1 |
p. S16-S17
|
artikel
|
| 49 |
Identifying unmet needs and challenges in the definition of a plaque in mycosis fungoides: an EORTC-CLG/ISCL survey
|
Roccuzzo, G
|
|
|
173 |
S1 |
p. S11
|
artikel
|
| 50 |
Illness perception of early-stage mycosis fungoides among dermatologists: a multi-center cross-sectional study
|
Barzilai, A
|
|
|
173 |
S1 |
p. S33
|
artikel
|
| 51 |
IL32β supports the HLA I expression on tumor skin T lymphocytes as a tumor immune escape mechanism in cutaneous T-cell lymphoma
|
Chang, YT
|
|
|
173 |
S1 |
p. S29
|
artikel
|
| 52 |
Immunophenotypic identification and characterization of CTCL tumor cells in blood using standardized flow cytometry: a European multicenter study
|
Najidh, S
|
|
|
173 |
S1 |
p. S1
|
artikel
|
| 53 |
Intralesional brentuximab vedotin: our experience in the treatment of CD30+ primary cutaneous T-cell lymphomas
|
Andrés, JA Arroyo
|
|
|
173 |
S1 |
p. S50-S51
|
artikel
|
| 54 |
Investigating clinical characteristics and outcomes of CTCL patients with a history of eczema: retrospective review at a single tertiary referral center
|
Talluru, S
|
|
|
173 |
S1 |
p. S34-S35
|
artikel
|
| 55 |
Investigating clinical characteristics and outcomes of hypopigmented mycosis fungoides: retrospective review at a single tertiary referral center
|
Talluru, S
|
|
|
173 |
S1 |
p. S9
|
artikel
|
| 56 |
In vivo modelling of cutaneous T-cell lymphoma: the role of SOCS1
|
Luo, Y
|
|
|
173 |
S1 |
p. S8
|
artikel
|
| 57 |
Itch as a quality of life indicator in patients with cutaneous T cell lymphoma
|
Ottevanger, R
|
|
|
173 |
S1 |
p. S39
|
artikel
|
| 58 |
Kaposi sarcoma in a patient with Sézary syndrome
|
Kathrin, CM Rose
|
|
|
173 |
S1 |
p. S34
|
artikel
|
| 59 |
Lacutamab in patients with advanced mycosis fungoides according to KIR3DL2 expression: stage 1 results from the TELLOMAK phase 2 trial
|
Bagot, M
|
|
|
173 |
S1 |
p. S20-S21
|
artikel
|
| 60 |
Low vs. high-dose total skin electron beam therapy for mycosis fungoides: efficacy and safety analysis
|
Koumourtzis, MR
|
|
|
173 |
S1 |
p. S46
|
artikel
|
| 61 |
Lymph node infiltration in mycosis fungoides and Sézary syndrome: ultrasound features descriptive study
|
Mendez, V Gonzalez
|
|
|
173 |
S1 |
p. S14
|
artikel
|
| 62 |
Lymphomatoid papulosis associated with rosacea-like primary cutaneous B cell lymphoma, a rare association
|
Montoya, VH Garcia
|
|
|
173 |
S1 |
p. S33
|
artikel
|
| 63 |
Lymphomatoid papulosis in pediatric population: preliminary results of a multicenter retrospective cohort study
|
Blanchard, M
|
|
|
173 |
S1 |
p. S10-S11
|
artikel
|
| 64 |
Mogamulizumab-associated rashes may be related to improved therapeutic response in T-cell lymphomas
|
Pileri, A
|
|
|
173 |
S1 |
p. S19-S20
|
artikel
|
| 65 |
Mogamulizumab combined with extracorporeal photopheresis for the treatment of refractory mycosis fungoides and Sézary syndrome
|
Muniz, CA Rubio
|
|
|
173 |
S1 |
p. S51-S52
|
artikel
|
| 66 |
Molecular crosstalk between PLCγ1 and STAT3 in cutaneous T-cell lymphoma
|
Campbell, VR
|
|
|
173 |
S1 |
p. S8-S9
|
artikel
|
| 67 |
Mycosis fungoides in advanced stage: treatment with doxorubicin liposomal pegilated
|
Villarreal, L Calzado
|
|
|
173 |
S1 |
p. S45-S46
|
artikel
|
| 68 |
Mycosis fungoides in pediatric patients: a retrospective multi-center study
|
Garcia, L Serra
|
|
|
173 |
S1 |
p. S36-S37
|
artikel
|
| 69 |
Mycosis fungoides: molecular identity revealed by nanostring analysis
|
Alonso, R Alonso
|
|
|
173 |
S1 |
p. S3-S4
|
artikel
|
| 70 |
Near complete responses to concurrent brentuximab vedotin and ultra-hypofractionated low-dose total skin electron beam radiation in advanced CTCL
|
Oymanns, M
|
|
|
173 |
S1 |
p. S23
|
artikel
|
| 71 |
New type of mogamulizumab induced rash simulating Lupus miliaris disseminatus faciei
|
Mitteldorf, C
|
|
|
173 |
S1 |
p. S24
|
artikel
|
| 72 |
Ocular, meningeal and cerebral involvement of mycosis fungoides associated with an immunophenotypic switch from CD4+ to CD8+
|
Amatore, FA
|
|
|
173 |
S1 |
p. S35
|
artikel
|
| 73 |
On the use of thermography for the follow-up of cutaneous B-cell lymphomas: apropos of a case
|
Álvarez, J Ortiz
|
|
|
173 |
S1 |
p. S32
|
artikel
|
| 74 |
Photodynamic therapy for the treatment of primary cutaneous B-cell marginal zone lymphoma: a series of 4 patients
|
Toulemonde, E
|
|
|
173 |
S1 |
p. S47
|
artikel
|
| 75 |
Polatuzumab vedotin in combination with rituximab and bendamustine (Pola-RB) for relapsed primary cutaneous diffuse large B-cell lymphoma
|
Wilms, L
|
|
|
173 |
S1 |
p. S25
|
artikel
|
| 76 |
POT1 gene dysfunction in primary cutaneous T-cell lymphoma
|
Bakr, D
|
|
|
173 |
S1 |
p. S2
|
artikel
|
| 77 |
Preclinical investigation of combined NFkB inhibition and ECP in cutaneous T-cell lymphoma
|
Şener, ÖÇ
|
|
|
173 |
S1 |
p. S29
|
artikel
|
| 78 |
Primary cutaneous diffuse large B-cell lymphoma, leg type with spontaneous regression: report of 2 cases
|
Cardona, LP Gonzalez
|
|
|
173 |
S1 |
p. S31-S32
|
artikel
|
| 79 |
Primary cutaneous gamma-delta lymphoma responding only to mogamulizumab and total skin electron beam therapy
|
Kinberger, M
|
|
|
173 |
S1 |
p. S44
|
artikel
|
| 80 |
Primary cutaneous gamma-delta T-cell lymphoma: a devastating malignancy in wolf’s clothing in 13 patients
|
Geller, S
|
|
|
173 |
S1 |
p. S38-S39
|
artikel
|
| 81 |
Primary cutaneous large cell anaplastic lymphoma and lymphomatoid papulosis: patient demographics, treatment and outcomes from a supraregional skin lymphoma service
|
Patel, RR
|
|
|
173 |
S1 |
p. S37-S38
|
artikel
|
| 82 |
Primary subcutaneous panniculitis B-cell lymphoma: an exotic case
|
Montoya, VH Garcia
|
|
|
173 |
S1 |
p. S38
|
artikel
|
| 83 |
Prognostic factors in mycosis fungoides and Sezary syndrome: results from the PROCLIPI study
|
Scarisbrick, JJ
|
|
|
173 |
S1 |
p. S18
|
artikel
|
| 84 |
Proliferative tumor infiltrating lymphocytes within microenvironment impact prognosis in cutaneous B-cell lymphomas
|
Pham-Ledard, A
|
|
|
173 |
S1 |
p. S6-S7
|
artikel
|
| 85 |
Quality of life and its influencing factors in patients with primary cutaneous B-cell lymphomas
|
Schirren, AEC
|
|
|
173 |
S1 |
p. S20
|
artikel
|
| 86 |
Racial and ethnic factors associated with differences in the receipt of treatments for patients with mycosis fungoides
|
Brown-Korsah, J
|
|
|
173 |
S1 |
p. S10
|
artikel
|
| 87 |
Real-life evaluation of efficacy and tolerability of chlormethine gel in Italian centers
|
Alberti-Violetti, S
|
|
|
173 |
S1 |
p. S44
|
artikel
|
| 88 |
Real-world study of the use of pegylated interferon alfa for treatment of primary cutaneous T-cell lymphomas: an EORTC CLTF study
|
Mitsunaga, K
|
|
|
173 |
S1 |
p. S24-S25
|
artikel
|
| 89 |
Relationship between skin, blood and lymph node responses in patients treated with mogamulizumab: post hoc analysis of the MAVORIC Trial
|
Scarisbrick, J
|
|
|
173 |
S1 |
p. S42
|
artikel
|
| 90 |
Risk of progression of early-stage mycosis fungoides from RNA analysis
|
Moneva, V Gargallo
|
|
|
173 |
S1 |
p. S4
|
artikel
|
| 91 |
SARSCOV-2 vaccine associated with primary cutaneous peripheral T cell lymphoma
|
Montoya, VH Garcia
|
|
|
173 |
S1 |
p. S32-S33
|
artikel
|
| 92 |
Single-cell RNA sequencing analyses of primary cutaneous B-cell disorders reveal distinct molecular patterns consistent with clinical behavior
|
Griss, JG
|
|
|
173 |
S1 |
p. S4
|
artikel
|
| 93 |
Single-cell RNA sequencing reveals race-based heterogeneity of malignant T-cells and skin microenvironment in patients with cutaneous T-cell lymphoma
|
Talluru, S
|
|
|
173 |
S1 |
p. S3
|
artikel
|
| 94 |
Skin directed therapy superior to systemic treatment in primary cutaneous B-cell lymphoma? A study from the Charité cutaneous lymphoma registry on time to next treatment
|
Cankaya, R
|
|
|
173 |
S1 |
p. S51
|
artikel
|
| 95 |
Structural variations in low tumor fraction mycosis fungoides unraveled by nanopore sequencing
|
Hain, C
|
|
|
173 |
S1 |
p. S31
|
artikel
|
| 96 |
Table of Contents
|
|
|
|
173 |
S1 |
p. iii
|
artikel
|
| 97 |
Targeting CD70 in cutaneous T-cell lymphoma using an antibody-drug conjugate, SGN-CD70A, in patient-derived xenograft models
|
Zhuang, WA Ai
|
|
|
173 |
S1 |
p. S17
|
artikel
|
| 98 |
Targeting immunosuppressive macrophages in the cutaneous T-cell lymphoma microenvironment
|
Portocarrero, C
|
|
|
173 |
S1 |
p. S1-S2
|
artikel
|
| 99 |
The COBALT-LYM study of CTX130: a phase 1 dose escalation study of CD70-targeted allogeneic CRISPR-Cas9–engineered CAR T cells in patients with relapsed/refractory (R/R) T-cell malignancies
|
Zain, DR
|
|
|
173 |
S1 |
p. S21
|
artikel
|
| 100 |
The effect of mogamulizumab on the malignant T cell population: a monocentric retrospective analysis
|
Gosmann, JG
|
|
|
173 |
S1 |
p. S26
|
artikel
|
| 101 |
The Sponsor Acknowledgment and Introduction
|
|
|
|
173 |
S1 |
p. iv-v
|
artikel
|
| 102 |
The utility of multiparametric ultrasonography combined with selective core-needle biopsy in detecting lymph node involvement in mycosis fungoides
|
Lampadaki, K
|
|
|
173 |
S1 |
p. S39
|
artikel
|
| 103 |
Time to next treatment and safety assessment in cutaneous-T-cell lymphomas: a retrospective analysis on patients treated with bexarotene and acitretin
|
Roccuzzo, GR
|
|
|
173 |
S1 |
p. S25-S26
|
artikel
|
| 104 |
Time to next treatment in early-stage mycosis fungoides: a retrospective study from the Charité cutaneous lymphoma registry
|
Schulz, S
|
|
|
173 |
S1 |
p. S51
|
artikel
|
| 105 |
Title Page
|
|
|
|
173 |
S1 |
p. i
|
artikel
|
| 106 |
Transcriptomic landscape of primary cutaneous diffuse large B-cell lymphoma, leg type reveals novel therapeutic clues
|
Gros, A
|
|
|
173 |
S1 |
p. S9
|
artikel
|
| 107 |
Transitioning to pegylated interferon for the treatment of cutaneous T-cell lymphoma: meeting the challenge of therapy discontinuation and a proposed algorithm
|
Osman, M
|
|
|
173 |
S1 |
p. S47-S48
|
artikel
|
| 108 |
Translational research linked to PIMTO-MF clinical
|
Ortiz-Romero, PL
|
|
|
173 |
S1 |
p. S7
|
artikel
|
| 109 |
Treatment-refractory bullous pemphigoid in a patient with Sézary syndrome
|
Blanchard, G
|
|
|
173 |
S1 |
p. S49
|
artikel
|
| 110 |
TUB-010, a novel antibody drug conjugate with reduced nonspecific toxicity profile based on Tub-tag technology widens the therapeutic window of targeting CD30
|
Gerlach, M
|
|
|
173 |
S1 |
p. S27
|
artikel
|
| 111 |
Unraveling tumor micro-environment by cellular and proteome analyses of suction blister fluid of early-stage mycosis fungoides lesions compared to non-lesional skin over time on chlormethine gel treatment using flow cytometry
|
Wind, SS
|
|
|
173 |
S1 |
p. S29
|
artikel
|
| 112 |
Update on the development of EORTC/CLTF questionnaires to assess HRQOL in primary cutaneous T-cell and B-cell lymphomas: phase I
|
Molloy, K
|
|
|
173 |
S1 |
p. S19
|
artikel
|
| 113 |
Use of the T cell receptor B-chain constant domains 1 and 2 (TCRBC1 and TCRBC2) studies for the analysis of T-cell clonality
|
Alonso, R Alonso
|
|
|
173 |
S1 |
p. S30-S31
|
artikel
|
| 114 |
What have we learnt about the treatment of advanced stage mycosis fungoides and Sezary syndrome from the PROCLIPI study?
|
Quaglino, P
|
|
|
173 |
S1 |
p. S18-S19
|
artikel
|
| 115 |
Whole-genome profiling of primary cutaneous anaplastic large cell lymphoma
|
Tensen, CP
|
|
|
173 |
S1 |
p. S2
|
artikel
|
Tijdschrift beschrijving